Introdução: A insuficiência cardíaca congestiva (ICC) ocasionada pela cardiomiopatia dilatada idiopática (CMDId) constitui-se em quadro causador de grande impacto na saúde pública, apresentando morbidade e mortalidade significativas, porém muitos aspectos referentes à sua fisiopatologia ainda permanecem desconhecidos, de modo que trabalhos que estudem tais aspectos poderão contribuir para melhor entendimento desta entidade. Objetivos: Avaliar aspectos anatômicos e histológicos de corações com CMDId e compará-los a um grupo controle de corações normais, obtendo-se as medidas dos perímetros dos anéis atrioventriculares direito (AVD) e esquerdo (AVE) e dos ventrículos direito (VD) e esquerdo (VE) bem como a porcentagem por área de fibras colágenas e elásticas dos anéis atrioventriculares direito e esquerdo. Métodos: Foram analisados 13 corações de pacientes que faleceram vítimas de CMDId e 13 corações normais de pacientes que faleceram por causas não relacionadas à doenças cardiovasculares. Os corações foram fixados em formol, dissecados de forma a manter-se apenas os anéis atrioventriculares e a massa ventricular, com posterior laminação desta em segmentos transversais correspondentes a 20%, 50% e 80% da distância compreendida entre o sulco atrioventricular e o ápice ventricular esquerdo. Os cortes assim obtidos foram submetidos à digitalização fotográfica, que permitiu a aferição de ambos os perímetros ventriculares por meio de software específico, tornando possível a comparação de tais medidas entre os grupos e os segmentos. Os anéis atrioventriculares foram posteriormente dissecados, fotografados e medidos digitalmente para aferição das medidas perimetrais a direita e a esquerda, sendo posteriormente enviados ao laboratório de anatomia patológica, sendo realizadas colorações por meio de hematoxilinaeosina, picrossírius e resorcina fuccina oxidada, permitindo estudo das fibras colágenas e elásticas. Resultados: Com relação aos segmentos ventriculares, notou-se que no grupo CMDId ocorre dilatação nos segmentos apical, equatorial e basal, tanto a direita quanto a esquerda A medida do AVD foi maior no grupo CMDId , não havendo diferença estatisticamente significante com relação ao AVE entre os dois grupos. Com relação ao percentual por área de fibras colágenas, tanto o AVE quanto o AVD apresentaram percentagem de fibras menor no grupo CMDId em relação ao grupo normal. Com relação ao percentual por área de fibras elásticas, não houve diferença entre os grupos. Conclusões: Ocorre alteração da geometria ventricular com dilatação tanto a direita quanto a esquerda no grupo CMDId, porém com comportamento distinto entre o VE e o VD. O anel atrioventricular esquerdo não se dilata, ao contrário do direito, a despeito do fato de em ambos ocorrer diminuição da área total de colágeno, sugerindo que o mecanismo de dilatação possa apresentar particularidades oriundas de diferenças estruturais e pressóricas em ambos os ventrículos / Introduction: Congestive heart failure caused by idiopathic dilated cardiomyopathy causes great impact on public health, with significant morbidity and mortality, but many aspects related to its pathophysiology remain unknown, so further studies can contribute to better understanding of this entity. Objectives: To evaluate anatomical and histological aspects of hearts from patients who died victims of idiopathic dilated cardiomyopathy and compare them to a control group, to evaluate the behavior of the perimeters of the right and left atrioventricular rings and left and right ventricles and to compare the percentage area of collagen and elastic fibers of the right and left atrioventricular rings in both groups. Methods: We analyzed 13 hearts of patients who died from idiopathic dilated cardiomyopathy and 13 normal hearts from patients who died of causes not related to cardiovascular disease. The hearts were fixed in formalin, dissected in order to keep only the ventricular mass and atrioventricular rings, with subsequent lamination of segments corresponding to 20%, 50% and 80% of the distance between the atrioventricular groove and the left ventricular apex . The sections obtained were subjected to photo scanning, which allowed the measurement of ventricular perimeters by means of specific software, making it possible to compare these measures between groups and segments. The atrioventricular rings were then dissected, photographed and measured digitally to evaluate the right and left perimeters, later being sent to the pathology laboratory, and stained by hematoxylin-eosin, picrosirius and oxidized resorcin fuccin, enabling study of collagen and elastic fibers. Results: Regarding to ventricular segments, it was noted that in the idiopathic dilated cardiomyopathy group dilation occurs in the apical, equatorial and basal segments, at both sides, and the right atrioventricular ring measurement was higher in idiopathic dilated cardiomyopathy group, with no statistically significant difference in the left side between the two groups. With respect to the percentage by area of collagen fibers, both the left and the right sides had lower percentage of fibers in the idiopathic dilated cardiomyopathy group compared to the normal group. With respect to the percentage by area of elastic fibers, there was no difference between the groups. Conclusions: There is a change in ventricular geometry in idiopathic dilated cardiomyopathy group, but with different behavior between the left and right ventricles. The left atrioventricular ring does not dilate, in spite of the fact that in both ventricles there is lowering of the total area of collagen, suggesting that the mechanism of dilation may present peculiarities arising from structural differences and pressure load in both ventricles

As the most commonly diseased valve of the heart, the mitral valve has been the subject of extensive research for many years. Prior research has focused on the development of surgical repair techniques and mainly consists of in vivo clinical studies into the efficacy and long-term effects of different procedures. There is a need for a means of studying the mitral valve ex vivo, incorporating patient data and the effects of different repair techniques on the valve prior to surgery. In this study, a method was developed for reconstructing the mitral valve from patient-specific data. Three-dimensional transthoracic and transesophageal echocardiography (3D-TTE and 3D-TEE) were used to obtain ultrasound images from a normal subject and a patient with mitral valve regurgitation. Geometric information was extracted from the images defining the primary structures of the mitral valve and a special program in MATLAB was created to automatically construct a finite element model of a valve. A dynamic finite element analysis solver, LS-DYNA 971, was used to simulate the dynamics of the valves and the non-linear, anisotropic behaviour of biological tissue. The two models were successful in simulating the dynamics of the mitral valve, with the subject model displaying normal function and the patient model showing the dysfunction displayed in the ultrasound images. A method was then developed to modify the original patient model, in a way that maintains its patient-specific nature, to model mitral valve repair. Four mitral valve repair techniques were simulated using the patient model: the annuloplasty ring, the double-orifice Alfieri stitch, the paracommissural Alfieri stitch, and the quadrangular resection. The former was coupled with the other three techniques, as is standard protocol in mitral valve repair. The effects of these techniques on the mitral valve were successfully determined, with varying degrees of improvement in valve function.

As the most commonly diseased valve of the heart, the mitral valve has been the subject of extensive research for many years. Prior research has focused on the development of surgical repair techniques and mainly consists of in vivo clinical studies into the efficacy and long-term effects of different procedures. There is a need for a means of studying the mitral valve ex vivo, incorporating patient data and the effects of different repair techniques on the valve prior to surgery. In this study, a method was developed for reconstructing the mitral valve from patient-specific data. Three-dimensional transthoracic and transesophageal echocardiography (3D-TTE and 3D-TEE) were used to obtain ultrasound images from a normal subject and a patient with mitral valve regurgitation. Geometric information was extracted from the images defining the primary structures of the mitral valve and a special program in MATLAB was created to automatically construct a finite element model of a valve. A dynamic finite element analysis solver, LS-DYNA 971, was used to simulate the dynamics of the valves and the non-linear, anisotropic behaviour of biological tissue. The two models were successful in simulating the dynamics of the mitral valve, with the subject model displaying normal function and the patient model showing the dysfunction displayed in the ultrasound images. A method was then developed to modify the original patient model, in a way that maintains its patient-specific nature, to model mitral valve repair. Four mitral valve repair techniques were simulated using the patient model: the annuloplasty ring, the double-orifice Alfieri stitch, the paracommissural Alfieri stitch, and the quadrangular resection. The former was coupled with the other three techniques, as is standard protocol in mitral valve repair. The effects of these techniques on the mitral valve were successfully determined, with varying degrees of improvement in valve function.

INTRODUÇÃO: Pacientes com insuficiência mitral crônica apresentam aumento da atividade simpática mesmo quando assintomáticos. Contudo, pouco se sabe sobre o efeito de drogas beta bloqueadoras ou de um programa de treinamento físico supervisionado como moduladores desta atividade simpática durante a evolução da doença. O objetivo deste estudo foi avaliar o efeito do carvedilol e de um programa de treinamento físico aeróbico regular sobre a evolução da insuficiência mitral crônica num modelo da doença em cães. Além disso, objetivou-se analisar as principais variáveis que atuam como preditoras de óbito. MÉTODOS: Foram selecionados 10 cães hígidos para padronização dos parâmetros normais. Outros 36 cães com diagnóstico de insuficiência mitral crônica foram divididos em 3 subgrupos (I, II e III). Do início do estudo (T0) até os 6 meses (T2), todos receberam tratamento clínico convencional (benazepril e digoxina, codeína, diurético quando necessário), sendo que no II (n=10) e III (n=13) associou-se o carvedilol durante todo o período, e no I (n=13) e II, após os 3 meses iniciais (T1), associou-se o treinamento físico supervisionado. As principais variáveis clínicas (número de intercorrências, peso, qualidade de vida avaliada pelo questionário FETCH, freqüência e ritmo cardíacos, classe funcional de insuficiência cardíaca e pressão arterial sistólica e diastólica); laboratoriais (norepinefrina, troponina I, sódio, uréia e creatinina) e ecodopplercardiográficas foram avaliadas. RESULTADOS: Não houve diferença de sobrevida entre os 3 subgrupos. Em relação às variáveis clínicas, observou-se melhora da qualidade de vida (FETCH) nos três subgrupos: I (T0= 5,56±4,67 vs T2=2,67±3,12; p<0,05), II (T0= 11,29±5,12 vs T2= 3± 3,32; p,0,05); III (T0= 15,50±9,94 vs T1=5 ±3,21 e T0 vs T2=4,25± 2,82; p<0,05). Quanto à freqüência cardíaca (em bpm) observaram-se diferenças (p=0,023) nos subgrupos: I (T0=139,44±22,97 vs T2=126,67±12,25), II (T0=128,57±31,32 vs T2=117,14± 25,63) e III (T0=142,50±53,39 vs T2=117,75±28,92). As demais variáveis clínicas, laboratoriais e ecodopplercardiográficas não apresentaram alterações. O grupo de animais que vieram a óbito apresentaram valores maiores para algumas variáveis em relação ao grupo não óbito, a saber: FETCH (23,67±9,66 vs 10,54±7,93; p<0,001), norepinefrina (684±378,12 vs 456,54±439,16 pg/ml; p=0,018) , troponina I (0,37 ±0,39 vs 0,09±0,14 ng/ml; p=0,007), freqüência cardíaca (158,33 ±22,5 vs 137,29 ±36,62 bpm; p=0,041), diâmetro diastólico (4,06±1,26 vs 3,06±0,78 cm; p=0,024) e sistólico (2,19± 0,84 vs 1,60±0,51 cm; p= 0,041) ventricular esquerdo e relação do diâmetro atrial esquerdo pela raiz da aorta (2,04± 0,39 vs 1,52±0,25; p<0,001) , além de ser composto majoritariamente por machos, em classe funcional III-IV e com ritmo cardíaco simpático. Foram selecionadas como preditores de óbito as variáveis: relação do diâmetro atrial esquerdo pela raiz da aorta, FETCH e ritmo cardíaco simpático. CONCLUSÕES: A associação do carvedilol e do programa de treinamento físico supervisionado ao tratamento convencional promoveu melhora da qualidade de vida e diminuição da FC mas não melhorou a sobrevida dos cães avaliados. As variáveis selecionadas como preditores de óbito foram: relação do diâmetro atrial esquerdo pela raiz da aorta, FETCH e ritmo cardíaco simpático. / INTRODUCTION: Sympathetic activation is present in patients having chronic mitral valve regurgitation even in asymptomatic ones. However, the effect of beta- blockers and a physical training program to modulate this sympathetic activation during this valve disease is unknown. The objective of this study has been to evaluate the effect of carvedilol and a physical aerobic training in the development of chronic mitral valve regurgitation in an experimental model of the disease in dogs. Moreover, the objective sought for some death predict variables in these dogs. METHODS: 10 healthy dogs were selected to evaluate the normal parameters. The other 36 chronic valve mitral regurgitation dogs were divided into 3 sub-groups (I, II e III). From the beginning of the study (T0) to 6 months (T2) all of them received the conventional treatment (Benazepril and Digoxine, codeine, diuretic when necessary). In the sub-group II (n=10) and III (n=13) the carvedilol was added to the treatment during all the study. In the sub-group I (n=13) and II, after the first 3 months (T1) the physical supervised training was added. The main clinical variables (number of interoccurrences, body weight, quality of life estimated by FETCH questionnaire, heart rate, cardiac rhythm, functional classification of heart failure, systolic and diastolic blood pressure), laboratory variables (norepinephrine, troponin I, sodium, urea, creatinine) and echodopplercardiographic variables were evaluated. RESULTS: The analyzes of the clinic variables showed an improvement in the quality of life (FETCH) in all the sub-groups: (T0= 5,56±4,67 vs T2=2,67±3,12; p<0,05), II (T0= 11,29±5,12 vs T2= 3± 3,32; p,0,05); III (T0= 15,50±9,94 vs T1=5 ±3,21 e T0 vs T2=4,25± 2,82; p<0,05). The heart rate (beats/min) results showed differences (p=0,023) in the sub-groups I (T0=139,44±22,97 vs T2=126,67±12,25), II (T0=128,57±31,32 vs T2=117,14± 25,63) and III (T0=142,50±53,39 vs T2=117,75±28,92). However, the other clinic, laboratory and echodopplercardiographic variables did not show any differences. The group of animals that died in comparison with the survivor group showed high values in some variables, as follows: FETCH (23,67±9,66 vs 10,54±7,93; p<0,001), norepinephrine (684±378,12 vs 456,54±439,16 pg/ml; p=0,018) , troponin I (0,37 ±0,39 vs 0,09±0,14 ng/ml; p=0,007), heart rate (158,33 ±22,5 vs 137,29 ±36,62 beats/min; p=0,041), diastolic left ventricular dimension (4,06±1,26 vs 3,06±0,78 cm; p=0,024), systolic left ventricular dimension (2,19± 0,84 vs 1,60±0,51 cm; p= 0,041) and left atrium to aortic root ratio (2,04± 0,39 vs 1,52±0,25; p<0,001). The death group in its majority comprehended male dogs in functional classification III-IV having sympathetic cardiac rhythm. The selected death predict variables were: left atrium to aortic root ratio, FETCH and sympathetic cardiac rhythm. CONCLUSION: The association of carvedilol as well as supervised physical training with the conventional treatment in dogs having chronic mitral valve regurgitation provided the improvement in quality of life but not in survival time and a decrease in the heart rate. The selected death predict variables were: left atrium to aortic root ratio, FETCH and sympathetic cardiac rhythm.

Introdução: A insuficiência cardíaca congestiva (ICC) ocasionada pela cardiomiopatia dilatada idiopática (CMDId) constitui-se em quadro causador de grande impacto na saúde pública, apresentando morbidade e mortalidade significativas, porém muitos aspectos referentes à sua fisiopatologia ainda permanecem desconhecidos, de modo que trabalhos que estudem tais aspectos poderão contribuir para melhor entendimento desta entidade. Objetivos: Avaliar aspectos anatômicos e histológicos de corações com CMDId e compará-los a um grupo controle de corações normais, obtendo-se as medidas dos perímetros dos anéis atrioventriculares direito (AVD) e esquerdo (AVE) e dos ventrículos direito (VD) e esquerdo (VE) bem como a porcentagem por área de fibras colágenas e elásticas dos anéis atrioventriculares direito e esquerdo. Métodos: Foram analisados 13 corações de pacientes que faleceram vítimas de CMDId e 13 corações normais de pacientes que faleceram por causas não relacionadas à doenças cardiovasculares. Os corações foram fixados em formol, dissecados de forma a manter-se apenas os anéis atrioventriculares e a massa ventricular, com posterior laminação desta em segmentos transversais correspondentes a 20%, 50% e 80% da distância compreendida entre o sulco atrioventricular e o ápice ventricular esquerdo. Os cortes assim obtidos foram submetidos à digitalização fotográfica, que permitiu a aferição de ambos os perímetros ventriculares por meio de software específico, tornando possível a comparação de tais medidas entre os grupos e os segmentos. Os anéis atrioventriculares foram posteriormente dissecados, fotografados e medidos digitalmente para aferição das medidas perimetrais a direita e a esquerda, sendo posteriormente enviados ao laboratório de anatomia patológica, sendo realizadas colorações por meio de hematoxilinaeosina, picrossírius e resorcina fuccina oxidada, permitindo estudo das fibras colágenas e elásticas. Resultados: Com relação aos segmentos ventriculares, notou-se que no grupo CMDId ocorre dilatação nos segmentos apical, equatorial e basal, tanto a direita quanto a esquerda A medida do AVD foi maior no grupo CMDId , não havendo diferença estatisticamente significante com relação ao AVE entre os dois grupos. Com relação ao percentual por área de fibras colágenas, tanto o AVE quanto o AVD apresentaram percentagem de fibras menor no grupo CMDId em relação ao grupo normal. Com relação ao percentual por área de fibras elásticas, não houve diferença entre os grupos. Conclusões: Ocorre alteração da geometria ventricular com dilatação tanto a direita quanto a esquerda no grupo CMDId, porém com comportamento distinto entre o VE e o VD. O anel atrioventricular esquerdo não se dilata, ao contrário do direito, a despeito do fato de em ambos ocorrer diminuição da área total de colágeno, sugerindo que o mecanismo de dilatação possa apresentar particularidades oriundas de diferenças estruturais e pressóricas em ambos os ventrículos / Introduction: Congestive heart failure caused by idiopathic dilated cardiomyopathy causes great impact on public health, with significant morbidity and mortality, but many aspects related to its pathophysiology remain unknown, so further studies can contribute to better understanding of this entity. Objectives: To evaluate anatomical and histological aspects of hearts from patients who died victims of idiopathic dilated cardiomyopathy and compare them to a control group, to evaluate the behavior of the perimeters of the right and left atrioventricular rings and left and right ventricles and to compare the percentage area of collagen and elastic fibers of the right and left atrioventricular rings in both groups. Methods: We analyzed 13 hearts of patients who died from idiopathic dilated cardiomyopathy and 13 normal hearts from patients who died of causes not related to cardiovascular disease. The hearts were fixed in formalin, dissected in order to keep only the ventricular mass and atrioventricular rings, with subsequent lamination of segments corresponding to 20%, 50% and 80% of the distance between the atrioventricular groove and the left ventricular apex . The sections obtained were subjected to photo scanning, which allowed the measurement of ventricular perimeters by means of specific software, making it possible to compare these measures between groups and segments. The atrioventricular rings were then dissected, photographed and measured digitally to evaluate the right and left perimeters, later being sent to the pathology laboratory, and stained by hematoxylin-eosin, picrosirius and oxidized resorcin fuccin, enabling study of collagen and elastic fibers. Results: Regarding to ventricular segments, it was noted that in the idiopathic dilated cardiomyopathy group dilation occurs in the apical, equatorial and basal segments, at both sides, and the right atrioventricular ring measurement was higher in idiopathic dilated cardiomyopathy group, with no statistically significant difference in the left side between the two groups. With respect to the percentage by area of collagen fibers, both the left and the right sides had lower percentage of fibers in the idiopathic dilated cardiomyopathy group compared to the normal group. With respect to the percentage by area of elastic fibers, there was no difference between the groups. Conclusions: There is a change in ventricular geometry in idiopathic dilated cardiomyopathy group, but with different behavior between the left and right ventricles. The left atrioventricular ring does not dilate, in spite of the fact that in both ventricles there is lowering of the total area of collagen, suggesting that the mechanism of dilation may present peculiarities arising from structural differences and pressure load in both ventricles

As the most commonly diseased valve of the heart, the mitral valve has been the subject of extensive research for many years. Prior research has focused on the development of surgical repair techniques and mainly consists of in vivo clinical studies into the efficacy and long-term effects of different procedures. There is a need for a means of studying the mitral valve ex vivo, incorporating patient data and the effects of different repair techniques on the valve prior to surgery. In this study, a method was developed for reconstructing the mitral valve from patient-specific data. Three-dimensional transthoracic and transesophageal echocardiography (3D-TTE and 3D-TEE) were used to obtain ultrasound images from a normal subject and a patient with mitral valve regurgitation. Geometric information was extracted from the images defining the primary structures of the mitral valve and a special program in MATLAB was created to automatically construct a finite element model of a valve. A dynamic finite element analysis solver, LS-DYNA 971, was used to simulate the dynamics of the valves and the non-linear, anisotropic behaviour of biological tissue. The two models were successful in simulating the dynamics of the mitral valve, with the subject model displaying normal function and the patient model showing the dysfunction displayed in the ultrasound images. A method was then developed to modify the original patient model, in a way that maintains its patient-specific nature, to model mitral valve repair. Four mitral valve repair techniques were simulated using the patient model: the annuloplasty ring, the double-orifice Alfieri stitch, the paracommissural Alfieri stitch, and the quadrangular resection. The former was coupled with the other three techniques, as is standard protocol in mitral valve repair. The effects of these techniques on the mitral valve were successfully determined, with varying degrees of improvement in valve function.

Pulmonary circulation is a high flow, low resistance, and low pressure system. Several pathologies, including mitral stenosis, may elevate the impedance of this blood circuit and lead to a pulmonary arterial hypertension. Such syndrome is usually related to a high morbity and patient s death may occur because of the ischemic failure of right ventricle. The use of systemic vasodilating drugs to treat this syndrome is limited by the simultaneous systemic arterial hypotension they often produce. More selective agents to the pulmonary vasculature, such as synthetic analogs of prostacyclin, endothelin receptor inhibitors, and phosphodiesterase III inhibitors, have been choosen for medium and long-term treatment. Unfortunately, the most selective pulmonary hypotensive agent, the inhaled nitric oxide, which is used for short-term treatment, requires special and costly equipment for its administration, making it inaccessible to many hospitals. Furthermore, some degree of toxicity was associated with that substance. The lack of an ideal substance that simultaneously shows pulmonary selectivity, atoxicity, easy handling, accessibility and low cost, motivated the present study to test the effects of clonidine on pulmonary circulation. Clonidine is an alfa-2 adrenergic agonist. It promotes a systemic cardiocirculatory balance by modulating the adrenergic discharge at both central and peripheral levels. When used in clinical doses it presents no toxicity. Furthermore, it is easy to handle, accessible, and inexpensive. However, little has been reported about its pulmonary effect. Therefore, this work aimed to evaluate the effects of clonidine on the pulmonary arterial pressure, on the hemodynamics parameters concerned to the pulmonary circulatory system, as well as on the right ventricular function. At the same time, the action of clonidine on the systemic hemodynamics, cardiac rate, cardiac index and stroke index was also evaluated. This investigation took into account the degree of selectivity of this agent to the pulmonary vessels as well as the presence of a biphasic effect on the pulmonary arterial pressure. This effect has been largely reported on the vascular periferal system. The present research was performed as a prospective clinical trial developed on a group of 16 patients with pulmonary hypertension caused by mitral stenosis of rheumatic origin. Data were obtained before the anesthetic induction, but under the patient sedation. During the control phase, the variations of hemodynamic parameters under the action of a placebo were evaluated. During the test phase, the behavior of these parameters was evaluated under the clonidine effect. The time schedule for data measurements was the following: T0 (initial control); T1 (10 minutes after placebo administration); T2 (20 minutes after placebo administration); T3 (10 minutes after clonidine administration); T4 (20 minutes after clonidine administration). T2 was used as the control time to study the clonidine effects. Statistical analysis showed that during the control phase the variables remained unchanged, but under the effect of clonidine there was a significant reduction of the mean values concerned to the following parameters: pulmonary arterial mean pressure (27.1%) and systemic arterial mean pressure (20%), pulmonary vascular resistance index (34%) and systemic vascular resistance index (14.6%), right and left ventricular systolic work indexes (19.9% and 10%, respectively), right atrium pressure (11.5%), pulmonary arterial wedge pressure (21.5%), heart rate and cardiac index (15.8% and 7.9%, respectively). Besides that, a significant increase of the stroke index (10.2%) occured. The biphasic effect on the sistemic arterial pressure occured in 50% of the studied patients, whereas the same effect on the pulmonary arterial pressure was observed in 20% of the same sample. Clonidine also exerted a moderately selective action on the pulmonary circulation, demonstrated through the reduction of the relationship between mean value of the pulmonary vascular resistance index and mean value of the systemic vascular resistance index evaluated at the times T2 and T3. / A circulação pulmonar é um sistema de alto fluxo, baixa resistência e baixa pressão. Patologias diversas, dentre elas a estenose mitral, podem elevar a impedância desse circuito, desencadeando a síndrome de hipertensão arterial pulmonar. Esta cursa com elevada morbidade, podendo levar ao óbito pela falência isquêmica do ventrículo direito. A utilização de drogas vasodilatadoras periféricas no tratamento dessa síndrome ficou limitada pela simultânea hipotensão arterial sistêmica que provoca. Agentes mais seletivos sobre a vasculatura pulmonar, como os análogos sintéticos da prostaciclina, os inibidores dos receptores de endotelina e os inibidores da fosfodiesterase III, têm sido as drogas de eleição para o tratamento de médio e de longo prazo. O mais seletivo dos agentes hipotensores pulmonares, o óxido nítrico inalado, aplicado ao tratamento de curto prazo, exige equipamento especial e oneroso para a sua administração, tornando-o inacessível a muitos nosocômios. Paralelamente, possui potencial toxicidade. A inexistência de um fármaco ideal que apresente, simultaneamente, seletividade sobre a pequena circulação, atoxicidade, fácil manuseio e disponibilidade, além de ser pouco oneroso, conduziu ao estudo da clonidina sobre a árvore circulatória pulmonar. Este agente terapêutico é um agonista alfa-2 adrenérgico, com efeitos favoráveis reconhecidos sobre o equilíbrio circulatório sistêmico por modular a descarga adrenérgica em níveis central e periférico. É atóxico quando utilizado em doses clínicas. Além disso, oferece fácil manuseio, boa acessibilidade e baixo custo. Os estudos a respeito da sua ação pulmonar são escassos. Assim, a presente investigação teve como objetivo avaliar os efeitos da clonidina sobre a pressão arterial pulmonar, sobre os demais parâmetros hemodinâmicos da pequena circulação e sobre a função ventricular direita. Paralelamente, analisou as ações sobre a hemodinâmica sistêmica, a freqüência cardíaca, o índice cardíaco e o índice de ejeção. Foi também investigado o grau de seletividade pulmonar desse agente, bem como a presença de um efeito bifásico sobre a pressão arterial pulmonar, pois este efeito tem sido amplamente relatado no sistema vascular periférico. Para a execução dos objetivos propostos, um ensaio clínico prospectivo, realizado antes da indução anestésica, mas sob sedação, foi desenvolvido num grupo de 16 pacientes, todos portadores de hipertensão pulmonar resultante de estenose mitral de origem reumática. Durante a fase controle foram analisadas as variações dos parâmetros hemodinâmicos sob a ação de um placebo. Durante a fase teste foi avaliado o comportamento dos mesmos parâmetros sob a ação da clonidina. A padronização dos tempos nos quais se fez a coleta de dados foi a seguinte: T0 (controle inicial); T1 (10 min após a administração do placebo); T2 (20 min após o placebo); T3 (10 min após a administração da clonidina); T4 (20 min após a clonidina). A análise estatística dos resultados demonstrou não haver alteração das variáveis estudadas durante a fase controle. Todavia, sob o efeito da clonidina houve variações estatisticamente significantes dos mesmos parâmetros nos seus valores médios: redução da pressão arterial pulmonar média (27,1%) e da pressão arterial sistêmica média (20%), dos índices de resistência vascular pulmonar (34%) e sistêmica (14,6%), dos índices de trabalho sistólico dos ventrículos direito (19,9%) e esquerdo (10%), da pressão do átrio direito (11,5%), da pressão de oclusão da artéria pulmonar (21,5%), da freqüência cardíaca (15,8%) e do índice cardíaco (7,9%), ao lado de uma elevação significante do índice de ejeção (10,2%). O efeito bifásico sobre a pressão arterial sistêmica ficou evidente em 50% dos pacientes estudados, enquanto que o mesmo efeito sobre a pressão arterial pulmonar ocorreu em 20% da amostra estudada. A clonidina também exerceu uma ação moderadamente seletiva sobre a circulação pulmonar, demonstrada através da diminuição do quociente obtido entre o valor médio do índice de resistência vascular pulmonar e valor médio do índice de resistência vascular sistêmica, ambos avaliados nos tempos T2 e T3.

Heutzutage stellt der Erhalt des posterioren Halteapparates beim Mitralklappenersatz (MKE) ein Routineverfahren dar. Das Ziel dieser Studie war es festzustellen, ob der komplette Erhalt der subvalvulären Strukturen beim Mitralklappenersatz Vor- oder Nachteile hat. Es wird über die Erfahrungen mit 48 Patienten berichtet. Die Gruppe MKEh bestand aus 15 Patienten, bei denen beim MKE der komplette subvalvuläre Halteapparat erhalten wurde. Die Gruppe MKEo, bei denen beim MKE nur der posteriore Halteapparat erhalten wurde, bestand aus 9 Patienten. Die dritte Gruppe (MKR) enthielt 12 Patienten, bei denen die Mitralklappe rekonstruiert worden war und die vierte Gruppe (KG) bestand aus 12 Herzgesunden ohne Klappendefekt, die die Kontrollgruppe darstellte. Die Patienten wurden einer ausführlichen Befragung unterzogen sowie prä- und postoperativ echokardiographisch untersucht und die Ergebnisse verglichen. Bezüglich der Ergebnisse der Befragungen und der präoperativen echokardiographischen Ergebnisse fanden sich bei den drei operierten Gruppen (MKEh, MKEo, MKR) keine signifikanten Unterschiede. Demgegenüber wurden postoperative Unterschiede festgestellt: Bei den Patienten mit MKE, bei denen aber der vordere Halteapparat nicht konserviert wurde (MKEo), fand sich eine signifikant geringere systolische Verkürzung zwischen dem Apex und der Mitralklappenbasis (6,5 mm - 15 mm), die systolische Kontraktion begann bei diesen Patienten außerdem nicht im Bereich des Apex und der posteriore Papillarmuskel führte in diesen Fällen keine aktive Kontraktion aus. Es konnte somit die Schlußfolgerung gezogen werden, daß der komplette subvalvuläre Apparat notwendig ist, damit der linke Ventrikel eine physiologische Kontraktion durchführen kann. Er sollte somit immer beim Mitralklappenersatz komplett erhalten werden, sofern die Papillarmuskeln und die Chorden intakt sind und keine Mitralklappenrekonstruktion durchgeführt werden kann. / Today preservation of the chordal attachment to the posterior leaflet in mitral valve replacement (MVR) is a routine, universally accepted procedure. The aim of this study was to show the advantages and disadvantages of the preservation of the entire subvalvular structures. Our institution's experience with 48 patients in four groups is reported. The MKEh group consists of 15 patients who underwent MVR with preservation of the entire subvalvular structures. The MKEo group, treated with MVR and preservation of the posterior subvalvular structures only, consists of 9 patients. The third group (MVR) consists of 12 patients with mitral valve reconstruction and group 4 (CG) of 12 healthy individuals without heart valve dysfunction, as a control group. The patients were assessed by questioning and echocardiography pre- and postoperatively and the results compared. In questioning and in the preoperative echocardiography results no differences were seen between the three surgical groups (MKEh, MKEo, MKR). However, considerable differences were present in the postoperative echocardiography results: in patients without preservation of the anterior subvalvular structures (MKEo group) the shortening between the apex and the mitral valve basis is significantly less (6.5 mm - 15 mm), the systolic contraction does not begin at the apex and the posterior papillary muscle does not actively contract. It is concluded that preservation of the entire subvalvular structures is important to ensure physiological contraction of the left ventricle. They should be preserved in all mitral valve replacement operations when the papillary muscles und chordae are intact and mitral valve reconstruction cannot be performed.

Myocardial infarction (i.e., a heart attack) is the most common heart disease in the United States. Mitral valve regurgitation, or the backflow of blood into the atrium from the left ventricle, is one of the complications associated with myocardial infarction. In this dissertation, a validated model of a sheep heart that has suffered myocardial infarction has been employed to study mitral valve regurgitation. The model was rebuilt with the knowledge of geometrical changes captured with MRI technique and is assigned with anisotropic, inhomogeneous, nearly incompressible and highly non-linear material properties. Patch augmentation was performed on its anterior leaflet, using a simplified approach, and its posterior leaflet, using a more realistic approach. In this finite element simulation, we virtually installed an elliptical patch within the central portion of the posterior leaflet. To the best of the author’s knowledge, this type of simulation has not been performed previously. In another simulation, the effect of patch within the anterior leaflet was simulated. The results from the two different surgical simulations show that patch implantation helps the free edges of the leaflets come close to one another, which leads to improved coaptation. Additionally, the changes in chordal force distributions are also reported. Finally, this study answers a few questions regarding mitral valve patch augmentation surgeries and emphasizes the importance of further investigations on the influence of patch positioning and material properties on key outcomes. The ultimate goal is to use the proposed techniques to assess human models that are patient-specific.

Change in papillary muscle motion as a result of left ventricular (LV) remodeling after posterolateral myocardial infarction is thought to contribute to ischemic mitral regurgitation. A finite element (FE) model of the LV was created from magnetic resonance images acquired immediately before myocardial infarction and 8 weeks later in a cohort of 12 sheep. Severity of mitral regurgitation was rated by two-dimensional echocardiography and regurgitant volume was estimated using MRI. Of the cohort, 6 animals (DC) received hydrogel injection therapy shown to limit ventricular remodeling after myocardial infarction while the control group (MI) received a similar pattern of saline injections. LV pressure was determined by direct invasive measurement and volume was estimated from MRI. FE models of the LV for each animal included both healthy and infarct tissue regions as well as a simulated hydrogel injection pattern for the DC group. Constitutive model material parameters for each region in the FE model were assigned based on results from previous research. Invasive LV pressure measurements at end diastole and end systole were used as boundary conditions to drive model simulations for each animal. Passive stiffness (C) and active material parameter (Tmax) were adjusted to match MRI estimations of LV volume at end systole and end diastole. Nodal positions of the chordae tendineae (CT) were determined by measurements obtained from the excised heart of each animal at the terminal timepoint. Changes in CT nodal displacements between end systole and end diastole at 0 and 8-week timepoints were used to investigate the potential contribution of changes in papillary muscle motion to the progression of ischemic mitral regurgitation after myocardial infarction. Nodal displacements were broken down into radial, circumferential, and longitudinal components relative to the anatomy of the individual animal model. Model results highlighted an outward radial movement in the infarct region after 8 weeks in untreated animals, while radial direction of motion observed in the treated animal group was preserved relative to baseline. Circumferential displacement decreased in the remote region in the untreated animal group after 8 weeks but was preserved relative to baseline in the treated animal group. MRI estimates of regurgitant volume increased significantly in the untreated animal group after 8 weeks but did not increase in the treated group. The results of this analysis suggest that hydrogel injection treatment may serve to limit changes in papillary muscle motion and severity of mitral regurgitation after posterolateral myocardial infarction.